NK Gen Biotech Korea (KRX: 182400)
Who is buying NK Gen Biotech Korea?
Between Sep 10, 2026 and Oct 13, 2026 (20 trading sessions), foreign investors were flat of NK Gen Biotech Korea, the 636th largest foreign net purchase among 1828 KOSDAQ stocks. Institutions were flat and retail investors were flat over the same window. Foreigners were net buyers on 0 of the 20 sessions.
Foreign investors hold 0% of NK Gen Biotech Korea's listed shares (KRX ownership data as of Oct 13, 2026), compared with 0% twenty sessions earlier and 0% a year ago.
The stock closed at ₩3,670 on Oct 13, 2026: 0.00% over 20 sessions, -0.41% year-to-date, -0.41% over one year.
View chart data as a table
| Date | Close | Foreign net | Institutions | Retail |
|---|---|---|---|---|
| 2026-10-13 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-10-12 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-10-08 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-10-07 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-10-06 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-10-02 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-10-01 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-09-30 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-09-29 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-09-28 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-09-23 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-09-22 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-09-21 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-09-18 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-09-17 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-09-16 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-09-15 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-09-14 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-09-11 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-09-10 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-09-09 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-09-08 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-09-07 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-09-04 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-09-03 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-09-02 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-09-01 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-08-31 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-08-28 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-08-27 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-08-26 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-08-25 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-08-24 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-08-21 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-08-20 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-08-19 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-08-18 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-08-14 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-08-13 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-08-12 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-08-11 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-08-10 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-08-07 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-08-06 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-08-05 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-08-04 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-08-03 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-07-31 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-07-30 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-07-29 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-07-28 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-07-27 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-07-24 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-07-23 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-07-22 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-07-21 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-07-20 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-07-16 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-07-15 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-07-14 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
| 2026-07-13 | ₩3,670 | ₩0.0bn | ₩0.0bn | ₩0.0bn |
Investor flows summary
| Window | Foreign | (USD) | Institutions | Retail |
|---|---|---|---|---|
| 1 day | ₩0.0bn | $0M | ₩0.0bn | ₩0.0bn |
| 5 days | ₩0.0bn | $0M | ₩0.0bn | ₩0.0bn |
| 20 days | ₩0.0bn | $0M | ₩0.0bn | ₩0.0bn |
Positive = net buying, negative = net selling. Values aggregate the KRX main board and the NXT alternative venue.
Frequently asked questions
Are foreign investors buying NK Gen Biotech Korea stock?
Over the last 5 sessions foreign investors were flat of NK Gen Biotech Korea; over 60 sessions they were flat; since Jan 1, 2026 they were flat. Over 20 sessions the stock is the 636th largest foreign net purchase among 1828 KOSDAQ stocks.
How much of NK Gen Biotech Korea do foreign investors own?
Foreign investors own 0% of NK Gen Biotech Korea's shares as of Oct 13, 2026, versus 0% one year earlier. The figure is KRX's daily foreign holdings divided by listed shares, and it reflects trades settled through the previous session.
Who is on the other side — institutions or retail investors?
Over 20 sessions institutions were flat and retail investors were flat of NK Gen Biotech Korea. No single investor group dominates the flow in this window.
Is NK Gen Biotech Korea listed on KOSPI or KOSDAQ?
NK Gen Biotech Korea (엔케이젠바이오텍코리아) trades on KOSDAQ under KRX code 182400 in the Biotech & Pharma group, with a market capitalization of ₩0T ($0.2B). Daily net flows by investor type are published by KRX after each session and combine the KRX main board with the NXT venue.
Annual financials
| Fiscal year | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| 2023 | – | – | -₩67bn (-$51M) | -₩153bn (-$115M) |
| 2024 | ₩9bn ($7M) | – | -₩4bn (-$3M) | -₩37bn (-$28M) |
| 2025 | ₩8bn ($6M) | -10.70% | -₩3bn (-$2M) | -₩7bn (-$6M) |
Consolidated (K-IFRS) where available, from DART regulatory filings. USD figures converted at the current rate (₩1333.09/$) for reference only.